US EditionTrump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shift
The move lets state-licensed medical cannabis and FDA-approved products move into Schedule III, easing research barriers and tax burdens, officials said.
- On Thursday, Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana from Schedule I to Schedule III, easing research barriers and granting licensed operators federal tax deductions.
- President Donald Trump ordered his administration in December to accelerate rescheduling. Blanche stated the action was "delivering on President Trump's promise" to expand Americans' access to medical treatment options.
- The action legitimizes medical marijuana systems in 40 states, shifting away from prohibition standards dating to the Marijuana Tax Act of 1937, while non-licensed marijuana remains strictly regulated under Schedule I.
- Although the order provides tax relief, it does not legalize marijuana for recreational use. In Washington, 302 of 460 licensed stores have endorsements allowing tax-free sales to registered patients.
- More than 20 Republican senators urged the president to maintain existing standards last year, and the Justice Department plans to launch administrative hearings in June to consider broader marijuana rescheduling.
381 Articles
381 Articles
The U.S. Department of Justice announced a downgrade in marijuana's status from the most dangerous drug to a lower one, reflecting a significant policy shift, although it remains illegal at the federal level.
The decision could reignite the debate on legalizing cannabis for recreational use, as well as prompt a review of existing legislation and regulations.
U.S. President Donald Trump's government issued an order Thursday to reclassify state-licensed medical marijuana as a less dangerous drug, a major policy change long claimed by advocates who argued that the federal government should never treat cannabis as heroin.
DOJ moves cannabis from heroin's schedule to Tylenol with codeine's
Acting Attorney General Todd Blanche signed an order Wednesday moving FDA-covered cannabis products and state-licensed medical marijuana from Schedule I — the same federal classification as heroin, reserved for drugs with "high potential for abuse" and "no currently accepted medical use" — to Schedule III, where it joins Tylenol with codeine. — Read the rest The post DOJ moves cannabis from heroin's schedule to Tylenol with codeine's appeared fi…
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
